|
Reactivity/ Applications |
Human/WB ELISA |
|
Size/Price |
50ug/1000 100ug/1800 |
|
Gene_Name/ Protein_Name |
TNFRSF13B/Tumor necrosis factor receptor superfamily member 13B |
|
Human_gene_id/ Human_swiss_prot_no |
23495/O14836 |
|
Mouse_gene_id/ Mouse_swiss_prot_no |
57916/Q9ET35 |
|
Immunogen |
Synthesized peptide derived from Tumor necrosis factor receptor superfamily member 13B at AA range: 81-130 |
|
Specificity |
CD267 Polyclonal Antibody detects endogenous levels of CD267 protein. |
|
Formulation |
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
|
|
Dilution |
Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications. |
|
Purification |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
|
|
Storage_stability |
-20°C/1 year |
|
Other_name |
TNFRSF13B; TACI; Tumor necrosis factor receptor superfamily member 13B; Transmembrane activator and CAML interactor; CD267 |
|
Predicted_band(Da)/ Observed_band(KD) |
31816/32 |
|
|
Content |
|
Western Blot analysis of NIH-3T3 cells using CD267 Polyclonal Antibody.. Secondary antibody(catalog#:RS0002) was diluted at 1:20000 |
|
|
Western Blot analysis of 3T3 cells using CD267 Polyclonal Antibody. Secondary antibody(catalog#:RS0002) was diluted at 1:20000 |
|
|